Cargando…
An integrated epigenome and transcriptome analysis identifies PAX2 as a master regulator of drug resistance in high grade pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is notoriously difficult to treat due to its aggressive, ever resilient nature. A major drawback lies in its tumor grade; a phenomenon observed across various carcinomas, where highly differentiated and undifferentiated tumor grades, termed as low and high gra...
Autores principales: | Aier, Imlimaong, Semwal, Rahul, Dhara, Aiindrila, Sen, Nirmalya, Varadwaj, Pritish Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797122/ https://www.ncbi.nlm.nih.gov/pubmed/31622355 http://dx.doi.org/10.1371/journal.pone.0223554 |
Ejemplares similares
-
PGC1 alpha coactivates ERG fusion to drive antioxidant target genes under metabolic stress
por: Dhara, Aiindrila, et al.
Publicado: (2022) -
Understanding the Mechanism of Cell Death in Gemcitabine Resistant Pancreatic Ductal Adenocarcinoma: A Systems Biology Approach
por: Aier, Imlimaong, et al.
Publicado: (2019) -
Identification of novel dysregulated key genes in Breast cancer through high throughput ChIP-Seq data analysis
por: Raj, Utkarsh, et al.
Publicado: (2017) -
Author Correction: Identification of novel dysregulated key genes in Breast cancer through high throughput ChIP-Seq data analysis
por: Raj, Utkarsh, et al.
Publicado: (2020) -
Sense of Smell: Structural, Functional, Mechanistic Advancements and Challenges in Human Olfactory Research
por: Sharma, Anju, et al.
Publicado: (2019)